233 related articles for article (PubMed ID: 10514420)
1. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors.
Jadeski LC; Lala PK
Am J Pathol; 1999 Oct; 155(4):1381-90. PubMed ID: 10514420
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis.
Jadeski LC; Hum KO; Chakraborty C; Lala PK
Int J Cancer; 2000 Apr; 86(1):30-9. PubMed ID: 10728591
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.
Jadeski LC; Chakraborty C; Lala PK
Int J Cancer; 2003 Sep; 106(4):496-504. PubMed ID: 12845643
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of nitric oxide synthase inhibitor L-NAME on oral squamous cell carcinoma: a preliminary study.
Shang ZJ; Li ZB; Li JR
Int J Oral Maxillofac Surg; 2006 Jun; 35(6):539-43. PubMed ID: 16497478
[TBL] [Abstract][Full Text] [Related]
5. A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model.
Uneda S; Hata H; Matsuno F; Nagasaki A; Harada N; Mitsuya Y; Matsuzaki H; Mitsuya H
Br J Haematol; 2003 Feb; 120(3):396-404. PubMed ID: 12580953
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelial nitric oxide synthase in endothelial cell migration.
Murohara T; Witzenbichler B; Spyridopoulos I; Asahara T; Ding B; Sullivan A; Losordo DW; Isner JM
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1156-61. PubMed ID: 10323764
[TBL] [Abstract][Full Text] [Related]
7. Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase.
Morais C; Ebrahem Q; Anand-Apte B; Parat MO
Am J Pathol; 2012 Apr; 180(4):1702-14. PubMed ID: 22322296
[TBL] [Abstract][Full Text] [Related]
8. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
Malone JM; Saed GM; Diamond MP; Sokol RJ; Munkarah AR
Am J Obstet Gynecol; 2006 Apr; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.
Hiraoka Y; Kishimoto C; Takada H; Nakamura M; Kurokawa M; Ochiai H; Shiraki K
J Am Coll Cardiol; 1996 Nov; 28(6):1610-5. PubMed ID: 8917278
[TBL] [Abstract][Full Text] [Related]
10. Constitutively synthesized nitric oxide is a physiological negative regulator of mammalian angiogenesis mediated by basic fibroblast growth factor.
Norrby K
Int J Exp Pathol; 2000 Dec; 81(6):423-7. PubMed ID: 11298189
[TBL] [Abstract][Full Text] [Related]
11. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
Orucevic A; Lala PK
Br J Cancer; 1996 Jan; 73(2):189-96. PubMed ID: 8546905
[TBL] [Abstract][Full Text] [Related]
12. The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice.
Orucevic A; Hearn S; Lala PK
Lab Invest; 1997 Jan; 76(1):53-65. PubMed ID: 9010449
[TBL] [Abstract][Full Text] [Related]
13. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
Orucevic A; Lala PK
Cell Immunol; 1996 Apr; 169(1):125-32. PubMed ID: 8612285
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
Ohtsu N; Takaoka K; Segawa E; Hashitani S; Noguchi K; Kishimoto H; Urade M
Oncol Rep; 2010 Jul; 24(1):31-6. PubMed ID: 20514441
[TBL] [Abstract][Full Text] [Related]
15. Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis.
Rikitake Y; Hirata K; Kawashima S; Ozaki M; Takahashi T; Ogawa W; Inoue N; Yokoyama M
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):108-14. PubMed ID: 11788469
[TBL] [Abstract][Full Text] [Related]
16. [Effect of nitric oxide derived from endothelial nitric oxide synthase on tumor angiogenesis].
Mei K; Cai XH; Du L; Chen YF; Huang S; Chen J; Yin XD; Zhang ZX; Zhao X; Zhou CY; Yu JR
Chin J Cancer; 2010 Jan; 29(1):32-7. PubMed ID: 20038308
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways.
Tamarat R; Silvestre JS; Durie M; Levy BI
Lab Invest; 2002 Jun; 82(6):747-56. PubMed ID: 12065685
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats.
Islas-Carbajal MC; Covarrubias A; Grijalva G; Alvarez-Rodríguez A; Armendáriz-Borunda J; Rincón-Sánchez AR
Liver Int; 2005 Feb; 25(1):131-40. PubMed ID: 15698410
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival.
Kane AJ; Barker JE; Mitchell GM; Theile DR; Romero R; Messina A; Wagh M; Fraulin FO; Morrison WA; Stewart AG
Br J Pharmacol; 2001 Apr; 132(8):1631-8. PubMed ID: 11309233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
